clonidine has been researched along with buprenorphine in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.08) | 18.7374 |
1990's | 13 (13.98) | 18.2507 |
2000's | 31 (33.33) | 29.6817 |
2010's | 41 (44.09) | 24.3611 |
2020's | 7 (7.53) | 2.80 |
Authors | Studies |
---|---|
Fraser, AD | 1 |
Haertzen, CA; Henningfield, JE; Jasinski, DR; Johnson, RE; Makhzoumi, HM; Miyasato, K | 1 |
Yang, G | 1 |
Cheskin, LJ; Fudala, PJ; Johnson, RE | 1 |
Janiri, L; Mannelli, P; Persico, AM; Serretti, A; Tempesta, E | 1 |
Bickel, WK; Higgins, ST; Hughes, JR | 1 |
Gold, MS | 1 |
Greenwood, J; Seivewright, NA | 1 |
Aggarwal, A; Batra, YK; Gill, PK; Vaidyanathan, S | 1 |
Nishimi, Y | 1 |
Connerney, I; Fischman, MW; Foltin, RW; Levin, FR | 1 |
Carroll, KM; Kosten, TR; O'Connor, PG; Rounsaville, BJ; Schottenfeld, RS; Shi, JM | 1 |
Abderrahim, N; Atyaoui, F; Cherif, A; Daghfous, M; Daoud, A; Ghazouani, S; Nafaa, N; Najah, N | 1 |
Chiang, CT; Demuth, KL; Hoover, DR; Montoya, ID; Preston, KL; Umbricht, A | 1 |
Bisaga, A; Popik, P; Radomska, M | 1 |
Alcorn, R; Feinmann, C; White, R | 1 |
Becker, R; Bertalanffy, H; Gatscher, S; Uhle, EI | 1 |
Bammer, G; Bell, J; Jolley, DJ; Lintzeris, N; Rushworth, L | 1 |
Chaisson, RE; Hoover, DR; Leslie, JM; Preston, KL; Tucker, MJ; Umbricht, A | 1 |
Kleber, HD | 1 |
Schnoll, SH | 1 |
Ali, R; Gowing, L; White, J | 2 |
Ellis, ML; Knox, PC; Malte, CA; Oreskovich, MR; Reoux, JP; Saxon, AJ | 1 |
O'Brien, CP | 1 |
Amass, L; Annon, JJ; Babcock, D; Brigham, G; Buchan, B; Harrer, J; Hillhouse, M; Krejci, J; Ling, W; Muir, J; Orr, D; Reid, M; Shoptaw, S; Woody, G; Ziedonis, D | 1 |
Collins, ED; Heitler, NE; Kleber, HD; Whittington, RA | 1 |
O'Connor, PG | 1 |
Bearn, J; de Wet, CJ; Glasper, A; Gossop, M; Reed, LJ | 1 |
Badger, GJ; Bickel, WK; Brooklyn, J; Marsch, LA; Quesnel, KJ; Stanger, C; Stothart, ME | 1 |
Banbery, J; Brearley, R; Finnegan, O; Raistrick, D; Thistlethwaite, G; West, D | 1 |
Miller, MM | 1 |
Besson, J; Favrat, B | 1 |
Contreras, JA | 1 |
de Jong, CJ | 1 |
Cohen, R; Grinshpoon, A; Margolis, A; Ponizovsky, AM; Rosca, P | 1 |
Gosciniak, JL; Lorman, WJ; Wallen, MC | 1 |
Cubells, JF; Tang, YL; Zhao, C; Zhao, D | 1 |
Clausen, T; Isaksen, A; Kristensen, Ø; Lølandsmo, T; Vederhus, JK | 1 |
Boverman, JF; Kovas, AE; McCarty, DJ; McFarland, BH; Thayer, JA | 1 |
Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP | 1 |
Amass, L; Brigham, GS; Harrer, JM; Pelt, A; Winhusen, T | 1 |
Amass, L; Annon, JJ; Babcock, D; Brigham, G; Brown, LS; Buchan, BJ; Cohen, AJ; Horton, T; Krejci, J; Ling, W; Maslansky, R; McCarty, D; Muir, J; Orr, D; Reid, MS; Steinberg, M; Stine, SM; Waite-O'Brien, N; Winhusen, T; Woody, G; Ziedonis, DM | 1 |
Amato, L; Davoli, M; Minozzi, S | 1 |
Ali, R; Gowing, L; White, JM | 1 |
Meader, N | 1 |
Bramness, J; Gossop, M; Lobmaier, P; Waal, H | 1 |
Bonati, M; Clavenna, A; Fortinguerra, F; Maschi, S | 1 |
Davoody, L; Ji, Y; Keller, A; Lucas, JM; Masri, R; Quiton, RL | 1 |
Kasaba, T | 1 |
Bio, LL; Poon, CY; Siu, A | 1 |
Brummett, CM; Williams, BA | 1 |
Badger, GJ; Hofstein, Y; Marsch, LA; Moore, SK; Solhkhah, R | 1 |
Bisaga, A; Kosten, T; Nunes, EV; O'Connor, PG; Sigmon, SC; Woody, G | 1 |
Cunningham, P; Steele, A | 1 |
Law, F; Melichar, J; O'Shea, J; Praveen, KT | 1 |
Bailard, NS; Flores, RA; Ortiz, J | 1 |
Amato, L; Bellisario, C; Davoli, M; Minozzi, S | 1 |
Bagley, SM; Brogly, SB; Holland, E; Wachman, EM | 1 |
Butt, MT; Coffee, S; Pippi, MA; Williams, BA; Zeller, JR | 1 |
Cohen, PZ; Ibinson, JW; Mangione, MP; Scanlan, RL; Williams, BA | 1 |
Cohen, PZ; Ibinson, JW; Kmatz, AM; Mangione, MP; Modrak, RT; Rakesh, H; Tonarelli, EJ; Williams, BA | 1 |
Agage, DA; Epstein, DH; Ghitza, UE; Jobes, ML; Kennedy, AP; Kowalczyk, WJ; Phillips, KA; Preston, KL; Schmittner, JP | 1 |
Bisaga, A; Drill, ES; Khan, NA; Mogali, S; Nunes, E; Pavlicova, M; Sullivan, MA | 1 |
deWit, H | 1 |
Craig, EV; Dines, DM; Fields, KG; Goon, AK; Gordon, MA; Goytizolo, EA; Gulotta, LV; Holck, G; Lin, Y; Miu, TW; YaDeau, JT | 1 |
McPherson, C | 1 |
Ayanga, D; Kosten, TR; Shorter, D | 1 |
Cheng, DM; Gryczynski, G; Hui, D; Kim, H; Quinn, E; Samet, JH; Weinstein, ZM | 1 |
Bisaga, A; Carpenter, KM; Choi, CJ; Dakwar, E; Levin, FR; Mariani, JJ; Mishlen, K; Nunes, EV; Pavlicova, M; Sullivan, M | 1 |
Ali, R; Gowing, L; Mbewe, D; White, JM | 1 |
Bonant, SA; Podnar, SM; Schanck, AM; Williams, BA | 1 |
Bigelow, GE; Dunn, KE; Strain, EC; Tompkins, DA | 1 |
Alto, W; Gianutsos, P; Mancl, L; Plawman, A; Rudolf, G; Rudolf, V; Walsh, J | 1 |
Cooley, J; Hoyt, MR; Shah, U; Temple, M | 1 |
Schiff, DM; Silverstein, M; Wachman, EM | 1 |
Bertz, JW; Epstein, DH; Ghitza, UE; Kowalczyk, WJ; Lin, JL; Moran, LM; Phillips, KA; Preston, KL; Vahabzadeh, M | 1 |
Dobson, SW; Edwards, CJ; Henshaw, DS; Jaffe, JD; Reynolds, JW; Russell, GB; Turner, JD; Weller, RS | 1 |
Amato, L; Amin-Esmaeili, M; Gholami, J; Hoseinie, L; Rahimi-Movaghar, A; Yousefi-Nooraie, R | 1 |
Bigelow, GE; Dunn, KE; Huhn, AS; Schroeder, JR; Strain, EC; Tompkins, DA; Weerts, EM | 1 |
Barnett, BS; Suzuki, J; Ward, HB | 1 |
Jones, HE; Kraft, WK | 1 |
Kahan, M; Njoroge, I; Sommer, LZ; Srivastava, A | 1 |
Ghazanfarpour, M; Keramat-Roudi, A; Mashhadi, ME; Mégarbane, B; Moghaddam, MMM; Najafi, MN; Rezaee, R; Roozbeh, N; Tsatsakis, A | 1 |
Ackerman, KJ; Dang, DY; Griffin, MJ; Haytmanek, CT; Hirose, CB; McGarry, SM; Melbihess, EJ; Stith, AT | 1 |
Ezaru, CS; Gilbert, KL; Ibinson, JW; Mikolic, JM; Muluk, VS; Paiste, HJ; Piva, SR; Rakesh, HR; Ritter, ME; Williams, BA | 1 |
Davey, JG; Martin, J; Osborn, DA; Zankl, A | 1 |
Bonant, SA; Boudreaux-Kelly, MY; Ezaru, CS; Gilbert, KL; Ibinson, JW; Mikolic, JM; Muluk, VS; Paiste, HJ; Piva, SR; Ritter, ME; Williams, BA | 1 |
Manu, P; Rogozea, LM; Shulman, M | 1 |
Acton, EK; Bilker, WB; Brensinger, CM; Dawwas, GK; Hennessy, S; Leonard, CE; Li, L; Miano, TA; Neuman, M; Nguyen, TPP; Soprano, SE; Wang, L; Woody, G; Yu, E | 1 |
Maiti, R; Mishra, BR; Mohapatra, D; Padhan, M | 1 |
30 review(s) available for clonidine and buprenorphine
Article | Year |
---|---|
Clinical toxicology of drugs used in the treatment of opiate dependency.
Topics: Buprenorphine; Clonidine; Humans; Methadone; Methadyl Acetate; Naltrexone; Opioid-Related Disorders | 1990 |
Common errors in the pharmacologic treatment of drug dependence and withdrawal.
Topics: Behavior Therapy; Buprenorphine; Clonidine; Humans; Lithium; Methadone; Narcotics; Nicotine; Psychotherapy; Substance Withdrawal Syndrome; Thiamine | 1994 |
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Topics: Animals; Buprenorphine; Clonidine; Humans; Locus Coeruleus; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1993 |
What is important in drug misuse treatment?
Topics: Buprenorphine; Clonidine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; United Kingdom | 1996 |
[Contemporary methods in pharmacotherapy in the opiate dependent treatment].
Topics: Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Heroin Dependence; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics | 2000 |
Pharmacologic treatments for heroin and cocaine dependence.
Topics: Buprenorphine; Clonidine; Cocaine-Related Disorders; Comorbidity; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics | 2003 |
Buprenorphine for the management of opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2004 |
Buprenorphine for the management of opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2006 |
Opiate addiction in China: current situation and treatments.
Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Sympatholytics | 2006 |
Detoxification treatments for opiate dependent adolescents.
Topics: Adolescent; Buprenorphine; Clonidine; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2009 |
Buprenorphine for the management of opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2009 |
A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Data Interpretation, Statistical; Humans; Methadone; Narcotic Antagonists; Narcotics; Odds Ratio; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
The pharmacological treatment of opioid addiction--a clinical perspective.
Topics: Adrenergic Agonists; Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Social Support; Substance Withdrawal Syndrome | 2010 |
Pain management in the paediatric population: the regulatory situation in Europe.
Topics: Adolescent; Analgesics; Buprenorphine; Child; Child, Preschool; Clonidine; Drug and Narcotic Control; Europe; Humans; Infant; Infant, Newborn; Ketamine; Pain; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2010 |
[Some adjuvants added to local anesthetics improve the duration and quality of epidural anesthesia].
Topics: Adjuvants, Anesthesia; Amines; Analgesics, Opioid; Anesthesia, Epidural; Anesthetics, Local; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Dexmedetomidine; Droperidol; Drug Compounding; Epinephrine; Fentanyl; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Magnesium Sulfate; Midazolam; Morphine; Neostigmine | 2010 |
Update on the pharmacologic management of neonatal abstinence syndrome.
Topics: Benzodiazepines; Buprenorphine; Clonidine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Phenobarbital; Pregnancy | 2011 |
Additives to local anesthetics for peripheral nerve blockade.
Topics: Anesthetics, Local; Buprenorphine; Clonidine; Dexmedetomidine; Epinephrine; Humans; Midazolam; Nerve Block; Sodium Bicarbonate; Tramadol | 2011 |
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clinical Protocols; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2012 |
Additives to local anesthetics for peripheral nerve blocks: Evidence, limitations, and recommendations.
Topics: Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents; Buprenorphine; Clonidine; Dexamethasone; Dexmedetomidine; Drug Combinations; Epinephrine; Evidence-Based Medicine; Humans; Ketamine; Magnesium Compounds; Midazolam; Nerve Block; Peripheral Nerves; Sodium Bicarbonate; Tramadol; Vasoconstrictor Agents | 2014 |
Detoxification treatments for opiate dependent adolescents.
Topics: Adolescent; Buprenorphine; Clonidine; Humans; Maintenance Chemotherapy; Naloxone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Randomized Controlled Trials as Topic | 2014 |
Review of the assessment and management of neonatal abstinence syndrome.
Topics: Breast Feeding; Buprenorphine; Clonidine; Female; Humans; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2014 |
Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
Topics: Analgesics; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Phenobarbital | 2016 |
Update on pharmacotherapy for treatment of opioid use disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Combined Modality Therapy; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2016 |
Buprenorphine for managing opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2017 |
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Topics: Acupuncture Therapy; Analgesics; Breast Feeding; Buprenorphine; Clonidine; Female; Humans; Infant, Newborn; Methadone; Morphine; Mothers; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Rooming-in Care | 2018 |
Pharmacological therapies for management of opium withdrawal.
Topics: Amantadine; Amines; Baclofen; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Methadone; Opioid-Related Disorders; Opium; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2018 |
Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
Topics: Analgesia, Obstetrical; Analgesics; Analgesics, Opioid; Breast Feeding; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clonidine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Kangaroo-Mother Care Method; Maternal-Fetal Exchange; Methadone; Neonatal Abstinence Syndrome; Occupational Therapy; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Education as Topic; Phenobarbital; Physical Therapy Modalities; Pregnancy; Pregnancy Complications; Rooming-in Care | 2019 |
Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2019 |
Opioid treatment for opioid withdrawal in newborn infants.
Topics: Buprenorphine; Chlorpromazine; Clonidine; Diazepam; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Morphine; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Opium; Phenobarbital; Randomized Controlled Trials as Topic | 2021 |
Efficacy and safety of tramadol in the treatment of opioid withdrawal: A meta-analysis of randomized controlled trials.
Topics: Bayes Theorem; Buprenorphine; Clonidine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2023 |
30 trial(s) available for clonidine and buprenorphine
Article | Year |
---|---|
A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
Topics: Adult; Baltimore; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Middle Aged; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Urban Population | 1994 |
Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Neurologic Examination; Opioid-Related Disorders; Patient Admission; Phenethylamines; Substance Withdrawal Syndrome | 1994 |
Effect of epidural buprenorphine and clonidine on vesical functions in women.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Epidural; Analgesics, Opioid; Buprenorphine; Clonidine; Cystoscopy; Double-Blind Method; Female; Humans; Middle Aged; Urodynamics | 1996 |
A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buprenorphine; Clonidine; Cocaine; Drug Administration Schedule; Female; Humans; Inpatients; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxazepam; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Sympatholytics; Treatment Outcome | 1997 |
Three methods of opioid detoxification in a primary care setting. A randomized trial.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Buprenorphine; Clonidine; Double-Blind Method; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Primary Health Care; Substance Withdrawal Syndrome | 1997 |
Naltrexone shortened opioid detoxification with buprenorphine.
Topics: Adult; Analgesics; Area Under Curve; Buprenorphine; Clonidine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 1999 |
Continuous intrathecal clonidine administration for the treatment of neuropathic pain.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Analgesics; Analgesics, Opioid; Buprenorphine; Chronic Disease; Clonidine; Drug Therapy, Combination; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Morphine; Pain; Pain Measurement | 2000 |
A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.
Topics: Adult; Ambulatory Care; Buprenorphine; Clonidine; Female; Heroin Dependence; Humans; Male; Narcotics; Patient Compliance; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Sympatholytics | 2002 |
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adult; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; HIV Infections; Hospitalization; Humans; Injections, Intramuscular; Male; Methadone; Middle Aged; Narcotics; Pain Measurement; Receptors, Opioid; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Clonidine; Double-Blind Method; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Receptors, Opioid, mu; Time Factors | 2005 |
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.
Topics: Adult; Buprenorphine; Clonidine; Female; Humans; Inactivation, Metabolic; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders | 2005 |
Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Topics: Adult; Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2005 |
Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Behavior Therapy; Buprenorphine; Clonidine; Combined Modality Therapy; Double-Blind Method; HIV Infections; Humans; Narcotic Antagonists; Opioid-Related Disorders; Psychomotor Performance; Risk-Taking; Substance Withdrawal Syndrome; Treatment Outcome | 2005 |
A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
Topics: Adolescent; Adult; Buprenorphine; Clonidine; Community Mental Health Services; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome | 2005 |
Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
Topics: Adolescent; Adult; Analgesics; Analgesics, Opioid; Buprenorphine; Clonidine; Cross-Sectional Studies; Female; Health Status; Heroin Dependence; Humans; Male; Middle Aged; Self Efficacy; Social Support; Substance Withdrawal Syndrome | 2006 |
Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Buprenorphine; Carbamazepine; Clonidine; Comorbidity; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Opioid-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 2006 |
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Anxiety; Buprenorphine; Clonidine; Data Interpretation, Statistical; Depression; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; National Institute on Alcohol Abuse and Alcoholism (U.S.); Opioid-Related Disorders; Prognosis; Smoking; Socioeconomic Factors; Substance Abuse Detection; Substance Withdrawal Syndrome; Treatment Outcome; United States; Young Adult | 2009 |
A comparison of suboxone and clonidine treatment outcomes in opiate detoxification.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clonidine; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Quality Improvement; Rehabilitation Centers; Retrospective Studies; Risk; Young Adult | 2012 |
Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.
Topics: Adult; Analgesics; Buprenorphine; Clonidine; Craving; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Substance Withdrawal Syndrome; Treatment Outcome | 2015 |
Baseline characteristics of patients predicting suitability for rapid naltrexone induction.
Topics: Administration, Oral; Adult; Buprenorphine; Clonidine; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Selection; Prognosis | 2015 |
Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study.
Topics: Aged; Amides; Anesthetics, Local; Anti-Inflammatory Agents; Buprenorphine; Clonidine; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nerve Block; Pain Measurement; Pain, Postoperative; Prospective Studies; Ropivacaine | 2016 |
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Behavior Therapy; Buprenorphine; Clonidine; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Opioid-Related Disorders; Remission Induction; Secondary Prevention; Young Adult | 2017 |
Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
Topics: Adult; Analgesics; Analgesics, Opioid; Buprenorphine; Clonidine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome; Tramadol; Treatment Outcome; Young Adult | 2017 |
Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Affect; Buprenorphine; Clonidine; Craving; Double-Blind Method; Drug Therapy, Combination; Ecological Momentary Assessment; Female; Humans; Linear Models; Male; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2018 |
Single-Injection Adductor Canal Block With Multiple Adjuvants Provides Equivalent Analgesia When Compared With Continuous Adductor Canal Blockade for Primary Total Knee Arthroplasty: A Double-Blinded, Randomized, Controlled, Equivalency Trial.
Topics: Aged; Analgesia; Anesthetics, Local; Arthroplasty, Replacement, Knee; Bupivacaine; Buprenorphine; Catheterization; Clonidine; Dexamethasone; Double-Blind Method; Epinephrine; Female; Humans; Infusions, Parenteral; Injections; Male; Middle Aged; Nerve Block; Pain Management; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Prospective Studies | 2018 |
Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.
Topics: Adult; Analgesics; Buprenorphine; Clonidine; Cluster Analysis; Double-Blind Method; Female; Humans; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Phenotype; Severity of Illness Index; Substance Withdrawal Syndrome; Tramadol; Treatment Outcome | 2020 |
Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.
Topics: Adult; Buprenorphine; Clonidine; Emergency Service, Hospital; Female; Humans; Male; Narcotic Antagonists; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Substance Withdrawal Syndrome; Treatment Outcome | 2019 |
Comparison of Single-Agent Versus 3-Additive Regional Anesthesia for Foot and Ankle Surgery.
Topics: Anesthetics; Ankle; Bupivacaine; Buprenorphine; Clonidine; Dexamethasone; Double-Blind Method; Female; Foot; Humans; Male; Nerve Block; Orthopedic Procedures; Pain Measurement; Pain, Postoperative; Prospective Studies | 2019 |
Extended Perineural Analgesia After Hip and Knee Replacement When Buprenorphine-Clonidine-Dexamethasone Is Added to Bupivacaine: Preliminary Report from a Randomized Clinical Trial.
Topics: Analgesia; Anesthetics, Local; Bupivacaine; Buprenorphine; Clonidine; Dexamethasone; Double-Blind Method; Humans; Hypesthesia; Pain Measurement; Pain, Postoperative; Prospective Studies | 2020 |
Day-One Pain Reductions After Hip and Knee Replacement When Buprenorphine-Clonidine-Dexamethasone Is Added to Bupivacaine Nerve/Plexus Blocks: A Randomized Clinical Trial.
Topics: Anesthetics, Local; Bupivacaine; Buprenorphine; Clonidine; Dexamethasone; Double-Blind Method; Humans; Nerve Block; Pain, Postoperative; Prospective Studies | 2022 |
33 other study(ies) available for clonidine and buprenorphine
Article | Year |
---|---|
Progress report of the NIDA Addiction Research Center.
Topics: Analgesics; Buprenorphine; Chlordiazepoxide; Clonidine; Diazepam; Humans; Morphine; National Institutes of Health (U.S.); Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder; Tolmetin; United States | 1982 |
[Current status and prospectives of combating addiction of heroin].
Topics: Buprenorphine; Clonidine; Heroin Dependence; Humans; Methadone; Methadyl Acetate | 1995 |
Comparative study of epidurally administered clonidine and buprenorphine on anesthetic requirement and electroencephalographic activity.
Topics: Adrenergic alpha-Agonists; Adult; Anesthetics, Inhalation; Buprenorphine; Central Nervous System; Clonidine; Drug Synergism; Electroencephalography; Female; Halothane; Hemodynamics; Humans; Injections, Epidural; Middle Aged; Narcotic Antagonists | 1996 |
[Analgesia in thoracic injuries: a comparative study of 2 techniques of loco-regional analgesia].
Topics: Adult; Aged; Analgesia; Analgesia, Epidural; Analgesics; Analgesics, Opioid; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Buprenorphine; Clonidine; Humans; Lidocaine; Male; Middle Aged; Pleura; Rib Fractures; Thoracic Injuries; Time Factors | 1998 |
Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine.
Topics: Adult; Buprenorphine; Chi-Square Distribution; Clonidine; Community Health Services; Female; Humans; Logistic Models; Male; Narcotic Antagonists; Opioid-Related Disorders; Outcome Assessment, Health Care; Prospective Studies; Statistics, Nonparametric; Substance Withdrawal Syndrome | 2001 |
The emperor' s new clothes.
Topics: Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Clonidine; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Tramadol | 2003 |
Opiate detoxification: what are the goals?
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Goals; Humans; Opioid-Related Disorders | 2005 |
Methods of detoxification and their role in treating patients with opioid dependence.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Failure | 2005 |
Induction of patients with moderately severe methadone dependence onto buprenorphine.
Topics: Adult; Buprenorphine; Clonidine; Drug Administration Schedule; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Severity of Illness Index; Surveys and Questionnaires | 2005 |
Heroin detoxification.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2006 |
Heroin detoxification.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2006 |
Detoxification and treating opioid dependence.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2006 |
Detoxification and treating opioid dependence.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2006 |
Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.
Topics: Buprenorphine; Clonidine; Drug Combinations; Female; Humans; Inactivation, Metabolic; Male; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patients; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2006 |
Buprenorphine for acute heroin detoxification: diffusion of research into practice.
Topics: Acute Disease; Adult; Buprenorphine; Clonidine; Diffusion of Innovation; Female; Heroin; Heroin Dependence; Humans; Length of Stay; Male; Middle Aged; Narcotics; Oregon; Patient Acceptance of Health Care; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Using buprenorphine short-term taper to facilitate early treatment engagement.
Topics: Adult; Analgesics; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Clonidine; Drug Administration Schedule; Female; Humans; Male; Ohio; Opioid-Related Disorders; Patient Acceptance of Health Care; Patient Dropouts; Retrospective Studies; Substance Withdrawal Syndrome | 2007 |
Conditioned place preference reveals tonic pain in an animal model of central pain.
Topics: Analgesics; Animals; Buprenorphine; Clonidine; Conditioning, Operant; Disease Models, Animal; Electric Stimulation; Female; Hyperalgesia; Motor Cortex; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 2011 |
Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment.
Topics: Adolescent; Affective Symptoms; Ambulatory Care; Behavior Therapy; Buprenorphine; Clonidine; Combined Modality Therapy; Comorbidity; Double-Blind Method; Drug Evaluation, Preclinical; Female; Humans; Internal-External Control; Male; Mental Disorders; Opiate Substitution Treatment; Opioid-Related Disorders; Personality Inventory; Token Economy | 2011 |
Opioid dependence.
Topics: Buprenorphine; Clonidine; Evidence-Based Medicine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prognosis; Risk Factors; Substance Withdrawal Syndrome; Time Factors | 2012 |
Multimodal perineural analgesia with combined bupivacaine-clonidine-buprenorphine-dexamethasone: safe in vivo and chemically compatible in solution.
Topics: Analgesics; Animals; Bupivacaine; Buprenorphine; Clonidine; Dexamethasone; Drug Combinations; Male; Nerve Block; Rats; Rats, Sprague-Dawley | 2015 |
Clinical benchmarks regarding multimodal peripheral nerve blocks for postoperative analgesia: observations regarding combined perineural midazolam-clonidine-buprenorphine-dexamethasone.
Topics: Analgesics; Benchmarking; Buprenorphine; Clonidine; Dexamethasone; Drug Therapy, Combination; Humans; Midazolam; Nerve Block; Pain, Postoperative | 2015 |
Research priorities regarding multimodal peripheral nerve blocks for postoperative analgesia and anesthesia based on hospital quality data extracted from over 1,300 cases (2011-2014).
Topics: Analgesics; Buprenorphine; Clonidine; Dexamethasone; Drug Therapy, Combination; Humans; Midazolam; Nerve Block; Pain, Postoperative | 2015 |
A New Role for Clonidine in Addictions: Catching Relapses Before They Happen.
Topics: Analgesics; Buprenorphine; Clonidine; Craving; Female; Humans; Male; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2015 |
Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine.
Topics: Adult; Amines; Analgesics, Opioid; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Retrospective Studies | 2017 |
Technical Communication: Admixture of Bupivacaine-Clonidine-Buprenorphine-Dexamethasone at the Bedside in a Tertiary Care Hospital Block Room Is Not Associated with Any Apparent Burdens of Endotoxin or Microbial Growth.
Topics: Analgesics; Anesthetics, Local; Bupivacaine; Buprenorphine; Clonidine; Dexamethasone; Drug Compounding; Drug Contamination; Endotoxins; Humans; Nerve Block; Tertiary Care Centers | 2017 |
A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
Topics: Adult; Amines; Analgesics, Opioid; Buprenorphine; Clonidine; Counseling; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyzine; Male; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2018 |
Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study.
Topics: Adrenergic alpha-Agonists; Adult; Analgesia, Epidural; Analgesia, Obstetrical; Buprenorphine; Catheterization; Cesarean Section; Clonidine; Delivery, Obstetric; Female; Humans; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Pain Measurement; Pain, Postoperative; Pregnancy; Young Adult | 2018 |
Management of opioid withdrawal symptoms.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2018 |
Expanded table: Some drugs for management of opioid withdrawal symptoms.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2018 |
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
Topics: Adult; Antidiarrheals; Antiemetics; Antipruritics; Buprenorphine; Clonidine; Deprescriptions; Drug Substitution; Female; Humans; Loperamide; Methadone; Methocarbamol; Muscle Relaxants, Central; Naltrexone; Narcotic Antagonists; Ondansetron; Opiate Substitution Treatment; Opioid-Related Disorders; Promethazine; Substance Withdrawal Syndrome; Sympatholytics | 2019 |
Pharmacological Management of Heroin Withdrawal Syndrome: A Century of Expert Opinions in Cecil Textbook of Medicine.
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Expert Testimony; Heroin; Humans; Methadone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2022 |
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection.
Topics: Baclofen; Bayes Theorem; Benzodiazepines; Buprenorphine; Clonidine; Drug Interactions; Fluconazole; Humans; Methadone; Methocarbamol; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Quetiapine Fumarate; Simvastatin | 2022 |